REVERA Belsrus lawyers have prepared an overview of the key changes in pharmaceutical and healthcare legislation for Q3 2023.
From the overview you will learn about:
Dear journalists, the use of materials from REVERA website in publications is possible only after our written permission.
For approval of materials, please contact us by e-mail: i.antonova@revera.legal or Telegram: https://t.me/PR_revera.